On May 8, 2024, Maxpro Investment Co., Ltd filed an amendment to Schedule 13G, indicating a change in their holdings of Apollomics Inc. The filing, submitted to the United States Securities and Exchange Commission, shows that Maxpro Investment now beneficially owns 10,577,029 Class A ordinary shares of Apollomics, which represents approximately 9.70% of the company's issued and outstanding Class A ordinary shares. This ownership includes 10,194,634 shares and an additional 382,395 shares that are issuable upon the exercise of warrants within 60 days from the filing date. The amendment follows Apollomics Inc.'s private placement of 19,166,666 Class A ordinary shares to certain accredited investors, as reported on April 24, 2024. Maxpro Investment's filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Apollomics Inc.

On May 8, 2024, Maxpro Investment Co., Ltd filed an amendment to Schedule 13G, indicating a change in their holdings of Apollomics Inc. The filing, submitted to the United States Securities and Exchange Commission, shows that Maxpro Investment now beneficially owns 10,577,029 Class A ordinary shares of Apollomics, which represents approximately 9.70% of the company's issued and outstanding Class A ordinary shares. This ownership includes 10,194,634 shares and an additional 382,395 shares that are issuable upon the exercise of warrants within 60 days from the filing date. The amendment follows Apollomics Inc.'s private placement of 19,166,666 Class A ordinary shares to certain accredited investors, as reported on April 24, 2024. Maxpro Investment's filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Apollomics Inc.